BDSX vs. CRNC

Last updated Apr 2, 2026

Compare and contrast key facts about Biodesix, Inc. (BDSX) and Cerence Inc. (CRNC).

Performance

BDSX vs. CRNC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biodesix, Inc. (BDSX) and Cerence Inc. (CRNC). The values are adjusted to include any dividend payments, if applicable.

BDSX vs. CRNC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
BDSX Biodesix, Inc.	117.06%	-77.78%	-16.85%	-20.00%	-56.52%	-73.76%	57.38%
CRNC Cerence Inc.	-36.67%	36.18%	-60.07%	6.10%	-75.82%	-23.73%	73.42%

Fundamentals

Market Cap BDSX : $119.04M CRNC : $304.33M
EPS BDSX : -$4.62 CRNC : $0.01
PS Ratio BDSX : 1.27 CRNC : 0.94
Total Revenue (TTM) BDSX : $88.50M CRNC : $315.96M
Gross Profit (TTM) BDSX : $47.90M CRNC : $248.30M
EBITDA (TTM) BDSX : -$23.37M CRNC : $54.04M

Returns By Period

In the year-to-date period, BDSX achieves a 117.06% return, which is significantly higher than CRNC's -36.67% return.

BDSX

• 1D: 1.79%
• 1M: -6.29%
• YTD: 117.06%
• 6M: 92.44%
• 1Y: 21.76%
• 3Y*: -26.52%
• 5Y*: -48.45%
• 10Y*: —

CRNC

• 1D: 7.29%
• 1M: -12.65%
• YTD: -36.67%
• 6M: -46.69%
• 1Y: -14.20%
• 3Y*: -37.77%
• 5Y*: -40.83%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BDSX vs. CRNC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BDSX

BDSX Risk / Return Rank: 53
BDSX Sharpe Ratio Rank: 47
BDSX Sortino Ratio Rank: 63
BDSX Omega Ratio Rank: 60
BDSX Calmar Ratio Rank: 48
BDSX Martin Ratio Rank: 46

CRNC

CRNC Risk / Return Rank: 35
CRNC Sharpe Ratio Rank: 33
CRNC Sortino Ratio Rank: 40
CRNC Omega Ratio Rank: 39
CRNC Calmar Ratio Rank: 32
CRNC Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BDSX vs. CRNC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Biodesix, Inc. (BDSX) and Cerence Inc. (CRNC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BDSX	CRNC	Difference
Sharpe ratio Return per unit of total volatility	0.16	-0.15	+0.32
Sortino ratio Return per unit of downside risk	1.35	0.45	+0.90
Omega ratio Gain probability vs. loss probability	1.16	1.05	+0.11
Calmar ratio Return relative to maximum drawdown	0.28	-0.26	+0.53
Martin ratio Return relative to average drawdown	0.48	-0.60	+1.08
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BDSX vs. CRNC - Sharpe Ratio Comparison

The current BDSX Sharpe Ratio is 0.16, which is higher than the CRNC Sharpe Ratio of -0.15. The chart below compares the historical Sharpe Ratios of BDSX and CRNC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BDSX	CRNC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.16	-0.15	+0.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.48	-0.36	-0.12
Sharpe Ratio (All Time) Calculated using the full available price history	-0.40	-0.11	-0.29

Correlation

The correlation between BDSX and CRNC is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BDSX vs. CRNC - Dividend Comparison

Neither BDSX nor CRNC has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BDSX vs. CRNC - Drawdown Comparison

The maximum BDSX drawdown since its inception was -99.30%, roughly equal to the maximum CRNC drawdown of -98.22%. Use the drawdown chart below to compare losses from any high point for BDSX and CRNC.

Drawdown Indicators

	BDSX	CRNC	Difference
Max Drawdown Largest peak-to-trough decline	-99.30%	-98.22%	-1.08%
Max Drawdown (1Y) Largest decline over 1 year	-64.95%	-55.92%	-9.03%
Max Drawdown (5Y) Largest decline over 5 years	-98.92%	-98.09%	-0.83%
Current Drawdown Current decline from peak	-97.64%	-94.93%	-2.71%
Average Drawdown Average peak-to-trough decline	-85.34%	-62.17%	-23.17%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.27%	23.82%	+13.45%

Volatility

BDSX vs. CRNC - Volatility Comparison

Biodesix, Inc. (BDSX) has a higher volatility of 24.98% compared to Cerence Inc. (CRNC) at 15.44%. This indicates that BDSX's price experiences larger fluctuations and is considered to be riskier than CRNC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BDSX	CRNC	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.98%	15.44%	+9.54%
Volatility (6M) Calculated over the trailing 6-month period	80.13%	62.27%	+17.86%
Volatility (1Y) Calculated over the trailing 1-year period	133.30%	92.12%	+41.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	101.50%	112.97%	-11.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	101.71%	107.08%	-5.37%

Financials

BDSX vs. CRNC - Profitability Comparison

The chart below illustrates the profitability comparison between Biodesix, Inc. and Cerence Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BDSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Biodesix, Inc. reported a gross profit of 0.00 and revenue of 28.76M. Therefore, the gross margin over that period was 0.0%.

CRNC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Cerence Inc. reported a gross profit of 99.35M and revenue of 115.08M. Therefore, the gross margin over that period was 86.3%.

BDSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Biodesix, Inc. reported an operating income of -1.97M and revenue of 28.76M, resulting in an operating margin of -6.8%.

CRNC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Cerence Inc. reported an operating income of 29.31M and revenue of 115.08M, resulting in an operating margin of 25.5%.

BDSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Biodesix, Inc. reported a net income of -3.98M and revenue of 28.76M, resulting in a net margin of -13.8%.

CRNC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Cerence Inc. reported a net income of -5.24M and revenue of 115.08M, resulting in a net margin of -4.6%.